<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36813422</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Gastroenterology clinics of North America</Title><ISOAbbreviation>Gastroenterol Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Gastrointestinal and Hepatobiliary Symptoms and Disorders with Long (Chronic) COVID Infection.</ArticleTitle><Pagination><StartPage>139</StartPage><EndPage>156</EndPage><MedlinePgn>139-156</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gtc.2022.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-8553(22)00066-8</ELocationID><Abstract><AbstractText>Long COVID is a novel syndrome characterizing new or persistent symptoms weeks after COVID-19 infection and involving multiple organ systems. This review summarizes the gastrointestinal and hepatobiliary sequelae of long COVID syndrome. It describes potential biomolecular mechanisms, prevalence, preventative measures, potential therapies, and health care and economic impact of long COVID syndrome, particularly of its gastrointestinal (GI) and hepatobiliary manifestations.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rizvi</LastName><ForeName>Anam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, 270-05 76 th Avenue, New Hyde Park, NY 11040, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziv</LastName><ForeName>Yonatan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, 270-05 76 th Avenue, New Hyde Park, NY 11040, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crawford</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 270-05 76th Avenue, New Hyde Park, NY 11040, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trindade</LastName><ForeName>Arvind J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, 270-05 76th Avenue, New Hyde Park, NY 11040, USA. Electronic address: arvind.trindade@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gastroenterol Clin North Am</MedlineTA><NlmUniqueID>8706257</NlmUniqueID><ISSNLinking>0889-8553</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 infection</Keyword><Keyword MajorTopicYN="N">Chronic COVID</Keyword><Keyword MajorTopicYN="N">Gastrointestinal</Keyword><Keyword MajorTopicYN="N">Hepatobiliary</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>20</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36813422</ArticleId><ArticleId IdType="pmc">PMC9940919</ArticleId><ArticleId IdType="doi">10.1016/j.gtc.2022.09.002</ArticleId><ArticleId IdType="pii">S0889-8553(22)00066-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Dashboard Global Map. https://coronavirus.jhu.edu/ Available at: Accessed July 30 2022.</Citation></Reference><Reference><Citation>Leppkes M., Neurath M.F. Rear Window-What Can the Gut Tell Us About Long-COVID? Gastroenterology. 2022;163(2):376&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9175081</ArticleId><ArticleId IdType="pubmed">35660031</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., et al. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. Plos Med. 2021;18(9):e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence reviews 6 and 7: monitoring and referral. London: National Institute for Health and Care Excellence (NICE); 2020 Dec. (NICE Guideline, No. 188.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK567265/.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555769</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A&#xa0;Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. JAMA. 2020;324(22):2251&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., et al. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F., et al. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Boyton R.J. Decoding the unknowns in long covid. BMJ. 2021;372:n132.</Citation><ArticleIdList><ArticleId IdType="pubmed">33541867</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12(1):6571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazato Y., Morioka S., Tsuzuki S., et al. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect Dis. 2020;7(11):ofaa507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665672</ArticleId><ArticleId IdType="pubmed">33230486</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dowds J., O'Brien K., et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc. 2021;18(6):997&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., et al. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163(2):495&#x2013;506.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D.M., Summers L.H. The COVID-19 Pandemic and the $16 Trillion Virus. JAMA. 2020;324(15):1495&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D.M. The Economic Cost of Long COVID: An Update. 2022. https://scholar.harvard.edu/cutler/news/long-covid Available at: Accessed Aug 31, 2022.</Citation></Reference><Reference><Citation>Calculations &amp; Formulas. https://www.longhauler-advocacy.org/calculations-formulas Available at: Accessed Aug 31, 2022.</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield B.A., Bhatt D.L., Gersh B.J. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol. 2022;19(5):332&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Rep. 2021;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallieri F., Sellner J., Zedde M., et al. Neurologic complications of coronavirus and other respiratory viral infections. Handb Clin Neurol. 2022;189:331&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9418023</ArticleId><ArticleId IdType="pubmed">36031313</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A., Lyoubi A., Peiffer-Smadja N., et al. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris) 2021;177(1&#x2013;2):51&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G., Todisco M., Hota N., et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review. Eur J Neurol. 2021;28(11):3856&#x2013;3865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver S.A., Beaubien-Souligny W., Shah P.S., et al. The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis. Kidney Med. 2021;3(1):83&#x2013;98 e81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723763</ArticleId><ArticleId IdType="pubmed">33319190</ArticleId></ArticleIdList></Reference><Reference><Citation>Copur S., Berkkan M., Basile C., et al. Post-acute COVID-19 syndrome and kidney diseases: what do we know? J&#xa0;Nephrol. 2022;35(3):795&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924729</ArticleId><ArticleId IdType="pubmed">35294747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Xu E., et al. Kidney Outcomes in Long COVID. J&#xa0;Am Soc Nephrol. 2021;32(11):2851&#x2013;2862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C., Cong Y., Zhang H. COVID-19 and the Digestive System. Am J Gastroenterol. 2020;115(7):1003&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273952</ArticleId><ArticleId IdType="pubmed">32618648</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanopoulos M., Gkeros F., Doukatas A., et al. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020;26(31):4579&#x2013;4588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445869</ArticleId><ArticleId IdType="pubmed">32884218</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N&#xa0;Engl J Med. 2020;383(2):120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppkes M., Knopf J., Naschberger E., et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58:102925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397705</ArticleId><ArticleId IdType="pubmed">32745993</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E.F., et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y). 2022;3(6):371&#x2013;387 e379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., et al. Immunological dysfunction persists for 8&#xa0;months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70(7):1253&#x2013;1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., et al. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clin Infect Dis. 2020;71(10):2669&#x2013;2678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2022;71(1):222&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271&#x2013;280 e278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., et al. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831&#x2013;1833 e1833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmer D., Gilbert M., Borman R., et al. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1&#x2013;2):107&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">12459472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Ni C., Gao R., et al. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell. 2020;11(10):771&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164704</ArticleId><ArticleId IdType="pubmed">32303993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Beumer J., van der Vaart J., et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hung I.F.N., Chan P.P.Y., et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a hong kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159(1):81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninger J.M., Grant M.B., Sung J.J.Y. The role of angiotensin converting enzyme 2 in modulating gut microbiota, intestinal inflammation, and coronavirus infection. Gastroenterology. 2021;160(1):39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836226</ArticleId><ArticleId IdType="pubmed">33130103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T., Perlot T., Rehman A., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095315</ArticleId><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen C., Round J.L. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16(7):1024&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4143175</ArticleId><ArticleId IdType="pubmed">24798552</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Zogg H., Wei L., et al. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. J&#xa0;Neurogastroenterol Motil. 2021;27(1):19&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786094</ArticleId><ArticleId IdType="pubmed">33166939</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G., Lenti M.V., Cremon C., et al. Implications of SARS-CoV-2 infection for neurogastroenterology. Neurogastroenterol Motil. 2021;33(3):e14104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7995160</ArticleId><ArticleId IdType="pubmed">33591607</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin B., Singh R., Ha S.E., et al. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol. 2021;27(19):2341&#x2013;2352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8130047</ArticleId><ArticleId IdType="pubmed">34040326</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan S., Altayar O., Siddique S.M., et al. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020;159(1):320&#x2013;334 e327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212965</ArticleId><ArticleId IdType="pubmed">32407808</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasa S., Desai M., Thoguluva Chandrasekar V., et al. Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(6):e2011335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290409</ArticleId><ArticleId IdType="pubmed">32525549</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshazli R.M., Kline A., Elgaml A., et al. Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves. J&#xa0;Med Virol. 2021;93(5):2740&#x2013;2768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014082</ArticleId><ArticleId IdType="pubmed">33527440</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Tariq R., Jena A., et al. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis. Therap Adv Gastroenterol. 2022;15 17562848221118403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky J.R., Tao G., Lavery A.M., et al. Late Conditions Diagnosed 1-4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data-United States, 1 March-30 June 2020. Clin Infect Dis. 2021;73(Suppl 1):S5&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi A., Patel Z., Liu Y., et al. Gastrointestinal Sequelae 3 and 6 Months After Hospitalization for Coronavirus Disease 2019. Clin Gastroenterol Hepatol. 2021;19(11):2438&#x2013;2440 e2431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245666</ArticleId><ArticleId IdType="pubmed">34217880</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett J.W., Wainberg M., Elkind M.S.V., et al. Potential Long Coronavirus Disease 2019 Gastrointestinal Symptoms 6 Months After Coronavirus Infection Are Associated With Mental Health Symptoms. Gastroenterology. 2022;162(2):648&#x2013;650 e642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Houston K.V., Yoo B.-S., D&#x2019;Souza S.M., et al. Post-COVID-19 GI Manifestations: Are We in for the &#x201c;Long Haul&#x201d;. Americal J Gastroenterol Hepatol. 2021;2:01&#x2013;05.</Citation></Reference><Reference><Citation>Barbara G., Grover M., Bercik P., et al. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology. 2019;156(1):46&#x2013;58 e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309514</ArticleId><ArticleId IdType="pubmed">30009817</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurusamy S.R., Shah A., Talley N.J., et al. Small Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2021;116(5):935&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">33734110</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis K.G., Cryan J.F., Mayer E.A. The Microbiota-Gut-Brain Axis: From Motility to Mood. Gastroenterology. 2021;160(5):1486&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8634751</ArticleId><ArticleId IdType="pubmed">33493503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani M., Alizadeh-Tabari S., Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(2):132&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">31157418</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshal U.C., Ghoshal U., Rahman M.M., et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study. J&#xa0;Gastroenterol Hepatol. 2022;37(3):489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8657345</ArticleId><ArticleId IdType="pubmed">34672022</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmulson M., Ghoshal U.C., Barbara G. Managing the Inevitable Surge of Post-COVID-19 Functional Gastrointestinal Disorders. Am J Gastroenterol. 2021;116(1):4&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273261</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle M.E., Appleton A., Liu Q.R., et al. Human Type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Am J Pathol. 2021;191(9):1511&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8179718</ArticleId><ArticleId IdType="pubmed">34102107</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Li Y., Huang X., et al. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2. J&#xa0;Med Virol. 2020;92(11):2556&#x2013;2566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280739</ArticleId><ArticleId IdType="pubmed">32441816</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S., Gunst J.D., Mathiasen V., et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. 2021;8(4):ofab042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Messin L., Puyraveau M., Benabdallah Y., et al. COVEVOL: natural evolution at 6 Months of COVID-19. Viruses. 2021;13(11):2151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619893</ArticleId><ArticleId IdType="pubmed">34834958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank A., Tzortzini A., Kling E., et al. One year after mild COVID-19: the majority of patients maintain specific immunity, but one in four still suffer from long-term symptoms. J&#xa0;Clin Med. 2021;10(15)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347559</ArticleId><ArticleId IdType="pubmed">34362088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatley A.K., Juno J.A., Wang J.J., et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021;12(1):1162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896046</ArticleId><ArticleId IdType="pubmed">33608522</ArticleId></ArticleIdList></Reference><Reference><Citation>Allard L., Ouedraogo E., Molleville J., et al. Malnutrition: percentage and association with prognosis in patients hospitalized for coronavirus disease 2019. Nutrients. 2020;12(12):3679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7761464</ArticleId><ArticleId IdType="pubmed">33260603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pironi L., Sasdelli A.S., Ravaioli F., et al. Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease. Clin Nutr. 2021;40(3):1330&#x2013;1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450234</ArticleId><ArticleId IdType="pubmed">32900518</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L., De Lorenzo R., D'Amico M., et al. COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study. Clin Nutr. 2021;40(4):2420&#x2013;2426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598735</ArticleId><ArticleId IdType="pubmed">33160700</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker M.S., Landmesser U., von Haehling S., et al. Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers. J&#xa0;Cachexia Sarcopenia Muscle. 2021;12(1):9&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890265</ArticleId><ArticleId IdType="pubmed">33382211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos A., Joaquin C., Ros M., et al. Impact of COVID-19 on nutritional status during the first wave of the pandemic. Clin Nutr. 2021 doi: 10.1016/j.clnu.2021.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2021.05.001</ArticleId><ArticleId IdType="pmc">PMC8106234</ArticleId><ArticleId IdType="pubmed">34049748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B., Eser F., Kalem A.K., et al. Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19. J&#xa0;Med Virol. 2021;93(12):6566&#x2013;6574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni A.V., Kumar P., Tevethia H.V., et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52(4):584&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361465</ArticleId><ArticleId IdType="pubmed">32638436</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N&#xa0;Engl J Med. 2020;382(18):1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Olry A., Meunier L., Delire B., et al. Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same. Drug Saf. 2020;43(7):615&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279629</ArticleId><ArticleId IdType="pubmed">32514859</ArticleId></ArticleIdList></Reference><Reference><Citation>An Y.W., Song S., Li W.X., et al. Liver function recovery of COVID-19 patients after discharge, a follow-up study. Int J Med Sci. 2021;18(1):176&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738966</ArticleId><ArticleId IdType="pubmed">33390786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71(1):226&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth N.C., Kim A., Vitkovski T., et al. Post-COVID-19 Cholangiopathy: A Novel Entity. Am J Gastroenterol. 2021;116(5):1077&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Faruqui S., Okoli F.C., Olsen S.K., et al. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021;116(7):1414&#x2013;1425.</Citation><ArticleIdList><ArticleId IdType="pubmed">33993134</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh M., Crawford J. In: Pathology of the gastrointestinal tract, pancreas, liver and biliary tree. 4th Edition edition. RD O. JR G, editor. WB Saunders; Philadelphia, PA: 2022. Vascular Disorders of the Liver; pp. 1595&#x2013;1696.</Citation></Reference><Reference><Citation>Scheppach W., Druge G., Wittenberg G., et al. Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases. Crit Care Med. 2001;29(2):438&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">11246328</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooling J., Leal R. Secondary Sclerosing Cholangitis: a Review of Recent Literature. Curr Gastroenterol Rep. 2017;19(9):44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28752474</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonhardt S., Veltzke-Schlieker W., Adler A., et al. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases. Medicine (Baltimore) 2015;94(49):e2188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5008492</ArticleId><ArticleId IdType="pubmed">26656347</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih A.R., Hatipoglu D., Wilechansky R., et al. Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients. Arch Pathol Lab Med. 2022;146(10):1184&#x2013;1193.</Citation><ArticleIdList><ArticleId IdType="pubmed">35657750</ArticleId></ArticleIdList></Reference><Reference><Citation>Durazo F.A., Nicholas A.A., Mahaffey J.J., et al. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report. Transplant Proc. 2021;53(4):1132&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953456</ArticleId><ArticleId IdType="pubmed">33846012</ArticleId></ArticleIdList></Reference><Reference><Citation>Trindade A.J., Izard S., Coppa K., et al. Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study. J&#xa0;Intern Med. 2021;289(6):887&#x2013;894.</Citation><ArticleIdList><ArticleId IdType="pubmed">33341978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro A., De Grazia F., Lenti M.V., et al. Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy. Clin Res Hepatol Gastroenterol. 2021;45(3):101521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427596</ArticleId><ArticleId IdType="pubmed">32888875</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G., Maida M., Morreale G.C., et al. Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review with Meta-Analysis. Can J Gastroenterol Hepatol. 2021;2021:2534975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8429023</ArticleId><ArticleId IdType="pubmed">34513750</ArticleId></ArticleIdList></Reference><Reference><Citation>Inamdar S., Benias P.C., Liu Y., et al. Prevalence, Risk Factors, and Outcomes of Hospitalized Patients With Coronavirus Disease 2019 Presenting as Acute Pancreatitis. Gastroenterology. 2020;159(6):2226&#x2013;2228 e2222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448741</ArticleId><ArticleId IdType="pubmed">32860787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M.L., Jacobsen F., Pepe-Mooney B.J., et al. Clinicopathological findings in patients with COVID-19-associated ischaemic enterocolitis. Histopathology. 2021;79(6):1004&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444633</ArticleId><ArticleId IdType="pubmed">34292620</ArticleId></ArticleIdList></Reference><Reference><Citation>Balaphas A., Gkoufa K., Meyer J., et al. COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall. J&#xa0;Hepatol. 2020;73(6):1566&#x2013;1568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467103</ArticleId><ArticleId IdType="pubmed">32890595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund L.C., Hallas J., Nielsen H., et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21(10):1373&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., et al. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328(7):676&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararaman A., Ray M., Ravindra P.V., et al. Role of probiotics to combat viral infections with emphasis on COVID-19. Appl Microbiol Biotechnol. 2020;104(19):8089&#x2013;8104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434852</ArticleId><ArticleId IdType="pubmed">32813065</ArticleId></ArticleIdList></Reference><Reference><Citation>Marazzato M., Ceccarelli G., d'Ettorre G. Dysbiosis in SARS-CoV-2-Infected Patients. Gastroenterology. 2021;160(6):2195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773314</ArticleId><ArticleId IdType="pubmed">33387514</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) Chin Med J (Engl) 2020;133(9):1087&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213636</ArticleId><ArticleId IdType="pubmed">32358325</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi A., Jadhav S.B., Shah N. A&#xa0;Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution of Post-COVID Fatigue. Medicines (Basel) 2021;8(9):47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Liu P., Shi X.L., et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. 2020;69(6):1143&#x2013;1144.</Citation><ArticleIdList><ArticleId IdType="pubmed">32139552</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B., Wang Y., Wen D., et al. A&#xa0;Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N&#xa0;Engl J Med. 2020;382(19):1787&#x2013;1799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121492</ArticleId><ArticleId IdType="pubmed">32187464</ArticleId></ArticleIdList></Reference><Reference><Citation>Barazzoni R., Bischoff S.C., Breda J., et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020;39(6):1631&#x2013;1638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138149</ArticleId><ArticleId IdType="pubmed">32305181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>